A detailed history of Castleview Partners, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Castleview Partners, LLC holds 98 shares of ILMN stock, worth $14,147. This represents 0.01% of its overall portfolio holdings.

Number of Shares
98
Previous 99 1.01%
Holding current value
$14,147
Previous $12,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$105.28 - $135.9 $105 - $135
-1 Reduced 1.01%
98 $12,000
Q4 2023

Feb 05, 2024

SELL
$92.79 - $142.53 $124,524 - $191,275
-1,342 Reduced 93.13%
99 $13,000
Q3 2023

Oct 26, 2023

SELL
$128.91 - $192.44 $1,546 - $2,309
-12 Reduced 0.83%
1,441 $197,000
Q2 2023

Aug 14, 2023

BUY
$183.43 - $232.67 $9,905 - $12,564
54 Added 3.86%
1,453 $272,000
Q1 2023

May 15, 2023

SELL
$193.75 - $232.55 $14,337 - $17,208
-74 Reduced 5.02%
1,399 $325,000
Q4 2022

Feb 01, 2023

BUY
$187.24 - $242.74 $40,256 - $52,189
215 Added 17.09%
1,473 $297,000
Q3 2022

Nov 10, 2022

SELL
$177.23 - $227.44 $3.44 Million - $4.42 Million
-19,415 Reduced 93.91%
1,258 $240,000
Q2 2022

Aug 17, 2022

SELL
$181.58 - $368.0 $17.5 Million - $35.5 Million
-96,395 Reduced 82.34%
20,673 $3.81 Million
Q2 2022

Aug 16, 2022

BUY
$181.58 - $368.0 $21.1 Million - $42.9 Million
116,451 Added 18873.74%
117,068 $21.6 Million
Q1 2022

May 16, 2022

SELL
$303.87 - $423.8 $142 Million - $197 Million
-465,802 Reduced 99.87%
617 $215,000
Q4 2021

Feb 17, 2022

BUY
$347.28 - $421.83 $162 Million - $196 Million
465,413 Added 46263.72%
466,419 $177 Million
Q2 2021

Aug 17, 2021

BUY
$372.84 - $481.5 $375,077 - $484,389
1,006 New
1,006 $476,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Castleview Partners, LLC Portfolio

Follow Castleview Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.